Sec. Applied Genetic Epidemiology
Genetics of Tinnitus: Time to Biobank Phantom Sounds
- 1Experimental Audiology, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden
- 2Department of Molecular Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
- 3Department of Genetics, University of North Carolina, Chapel Hill, NC, United States
- 4Department of Psychiatry, University of North Carolina, Chapel Hill, NC, United States
- 5Otology & Neurotology Group, Department of Genomic Medicine, Pfizer-Universidad de Granada-Junta de Andalucía Centre for Genomics and Oncology Research (GENyO), Granada, Spain
- 6Department of Otolaryngology, Instituto de Investigación Biosanitaria ibs.GRANADA, Hospital Virgen de las Nieves, Universidad de Granada, Granada, Spain
Tinnitus is a common phantom sensation resulting most often from sensory deprivation, and for which little knowledge on the molecular mechanisms exists. While the existing evidence for a genetic influence on the condition has been until now sparse and underpowered, recent data suggest that specific forms of tinnitus have a strong genetic component revealing that not all tinnitus percepts are alike, at least in how they are genetically driven. These new findings pave the way for a better understanding on how phantom sensations are molecularly driven and call for international biobanking efforts.
For decades, tinnitus was considered a consequence of environmental factors, with low genetic contribution. The numerous etiologies, such as aging (presbycusis), noise exposure, stress, hypertension, diabetes, ototoxic medications, temporomandibular joint disorders, traumatic or ischemic damage, vascular problems, middle-ear problems, and the complex pathophysiology involving peripheral and central auditory and non-auditory structures, have led to the belief that tinnitus is a consequence of some other disease.
The knowledge on the genetic basis of tinnitus was recently reviewed (Vona et al., 2017) and phenotyping strategies have been proposed based on the assumption that tinnitus should be considered as an ensemble of sub-entities called subtypes (Lopez-Escamez et al., 2016). A small familial aggregation study (n = 198 families) found no obvious heritability (Hendrickx et al., 2007), and the first large population-based family study (n = 52,045) made an estimate of heritability of 0.11 (Kvestad et al., 2010). But a recent twin study revealed a higher heritability of 0.4, indicating that a larger fraction of the variance can be due to genetic variants than previously reported (Bogo et al., 2016). Such discrepancies may originate from differences in the design and formulation of the questionnaires, which have been found to vary greatly in prevalence studies on tinnitus (McCormack et al., 2016).
The tinnitus phenotype could also be grounds for diverging heritability values, but what defines a tinnitus phenotype is highly debated. We indeed consider that a more precise definition of a homogeneous phenotype will be essential in the design of genetic studies. A larger twin study performed by members of the TINNET1 consortium recently considered the laterality of tinnitus as a potential genetic subtype (Maas et al., 2017). A key finding was that bilateral tinnitus had higher heritability than unilateral tinnitus. The study was based on self-reported data from the Swedish Twin Registry, one of the largest twin registries in the world (Lichtenstein et al., 2002, 2006; Pedersen et al., 2002; van Dongen et al., 2012). Of a total of 70,186 twins that answered questions related to tinnitus, 15% of them experienced tinnitus. 10,464 concordant or discordant pairs for tinnitus were identified, in which 6,990 subjects had tinnitus. When considering tinnitus as a whole, a moderate genetic contribution (near 40%) was found (Bogo et al., 2016). However, when twins were stratified – based on tinnitus experienced in one ear (unilateral) or in both ears (bilateral) as well as on gender – bilateral tinnitus reached a heritability of 0.68 in men (Maas et al., 2017). Such values are close to the levels of heritability for schizophrenia and attention deficit hyperactive disorder (ADHD), two well known heritable conditions (Table 1). Although more work is required for establishing the contribution of hearing loss in such high heritability values (e.g., by including exhaustive auditory data), these findings open the possibility of specific forms of tinnitus being more genetically driven than others and pave the way for future genetic studies considering subtypes. These findings, however, need to be replicated in other twin cohorts as well as familial studies.
In line with genetic association studies of other complex traits, published studies to find genetic markers for chronic tinnitus patients in candidate genes have been underpowered (n = 95–288) and failed to identify robustly associated genetic variants (Sand et al., 2010, 2011, 2012a,b; Gallant et al., 2013). In spite of a lowly powered tinnitus group (N = 167) and no significant associations found, a recent genome-wide association study (GWAS) identified some pathways (e.g., oxidative stress, endoplasmatic reticulum stress, and serotonin reception mediated signaling) potentially involved in tinnitus (Gilles et al., 2017). Supporting the need of better characterizing the tinnitus cases, Pawelczyk and colleagues investigated 99 single nucleotide polymorphisms targeting 10 genes involved in the potassium recycling pathway in the inner ear (128 tinnitus cases and 498 controls both exposed to occupational noise) (Pawelczyk et al., 2012). However, two of the identified SNPs were not subjected to multiple testing and were thus considered nominally significant. An important lesson from GWAS on other complex traits, such as schizophrenia and major depressive disorder (Sullivan et al., in press), is that far larger sample sizes are needed in order to identify genome-wide significant genetic variants. Therefore, an important next step in the search for genetic variants associated with tinnitus will be to perform joint GWAS analysis of thousands of tinnitus patients and healthy controls.
Since familial tinnitus is a rare condition, the selection of multiplex tinnitus families, in addition to unrelated cases and controls, for exome sequencing, is another potential strategy to be used for the discovery of genes involved in tinnitus. This strategy has been successful in the identification of DTNA, PRKCB, SEMA3D and DPT in autosomal dominant Meniere disease (Requena et al., 2015; Martin-Sierra et al., 2016, 2017).
With tinnitus being a condition with highly unmet clinical needs (Cederroth et al., 2013), the recent identification of a high heritability opens door to exciting research. Since it is more than likely that tinnitus is a polygenic trait and it will require the study of several thousand samples, audiologists and ENT doctors should optimize their phenotyping strategies for instance by using high frequency audiometry and multivariate questionnaire data (Muller et al., 2016; Schlee et al., 2017), initiate incentives to allocate a specific ICD-code for bilateral tinnitus, and start biobanking samples (Lopez-Escamez et al., 2016). Regarding the latter, since it is not custom for an ENT clinic to collect samples for DNA biobanking, guidelines should emerge to promote good practice (Fuller et al., 2017) and enable the creation of a large consortium to join efforts to decipher the genetic basis of tinnitus.
CC conceived the paper and prepared the table. CC co-wrote the paper with JL-E. AK and PS helped to develop the scientific arguments. All authors played a role in writing the manuscript and approved the final version.
CC has received funding from Tysta Skolan, Karolinska Institutet, Lars Hiertas Minne, Magnus Bergvalls Stiftelserna, Hörselforskningsfonden, and Loo och Hans Ostermans. The work was supported by an independent research program funded under the Biomedicine and Molecular Biosciences European Cooperation in Science and Technology (COST) Action framework (TINNET BM1306).
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Bogo, R., Farah, A., Karlsson, K. K., Pedersen, N. L., Svartengren, M., and Skjonsberg, A. (2016). Prevalence, incidence proportion, and heritability for tinnitus: a longitudinal twin study. Ear Hear. 38, 292–300. doi: 10.1097/AUD.0000000000000397
Fuller, T. E., Haider, H. F., Kikidis, D., Lapira, A., Mazurek, B., Norena, A., et al. (2017). Different teams, same conclusions? A systematic review of existing clinical guidelines for the assessment and treatment of tinnitus in adults. Front. Psychol. 8:206. doi: 10.3389/fpsyg.2017.00206
Gallant, E., Francey, L., Fetting, H., Kaur, M., Hakonarson, H., Clark, D., et al. (2013). Novel COCH mutation in a family with autosomal dominant late onset sensorineural hearing impairment and tinnitus. Am. J. Otolaryngol. 34, 230–235. doi: 10.1016/j.amjoto.2012.11.002
Gilles, A., Van Camp, G., Van de Heyning, P., and Fransen, E. (2017). A pilot genome-wide association study identifies potential metabolic pathways involved in tinnitus. Front. Neurosci. 11:71. doi: 10.3389/fnins.2017.00071
Kvestad, E., Czajkowski, N., Engdahl, B., Hoffman, H. J., and Tambs, K. (2010). Low heritability of tinnitus: results from the second Nord-Trondelag health study. Arch. Otolaryngol. Head Neck Surg. 136, 178–182. doi: 10.1001/archoto.2009.220
Lichtenstein, P., De Faire, U., Floderus, B., Svartengren, M., Svedberg, P., and Pedersen, N. L. (2002). The Swedish Twin Registry: a unique resource for clinical, epidemiological and genetic studies. J. Intern. Med. 252, 184–205. doi: 10.1046/j.1365-2796.2002.01032.x
Lichtenstein, P., Sullivan, P. F., Cnattingius, S., Gatz, M., Johansson, S., Carlstrom, E., et al. (2006). The Swedish Twin Registry in the third millennium: an update. Twin Res. Hum. Genet. 9, 875–882. doi: 10.1375/183242706779462444
Lopez-Escamez, J. A., Bibas, T., Cima, R. F., Van de Heyning, P., Knipper, M., Mazurek, B., et al. (2016). Genetics of tinnitus: an emerging area for molecular diagnosis and drug development. Front. Neurosci. 10:377. doi: 10.3389/fnins.2016.00377
Maas, I. L., Bruggemann, P., Requena, T., Bulla, J., Edvall, N. K., Hjelmborg, J. V., et al. (2017). Genetic susceptibility to bilateral tinnitus in a Swedish twin cohort. Genet Med. doi: 10.1038/gim.2017.4 [Epub ahead of print].
Martin-Sierra, C., Gallego-Martinez, A., Requena, T., Frejo, L., Batuecas-Caletrio, A., and Lopez-Escamez, J. A. (2017). Variable expressivity and genetic heterogeneity involving DPT and SEMA3D genes in autosomal dominant familial Meniere’s disease. Eur. J. Hum. Genet. 25, 200–207. doi: 10.1038/ejhg.2016.154
Martin-Sierra, C., Requena, T., Frejo, L., Price, S. D., Gallego-Martinez, A., Batuecas-Caletrio, A., et al. (2016). A novel missense variant in PRKCB segregates low-frequency hearing loss in an autosomal dominant family with Meniere’s disease. Hum. Mol. Genet. 25, 3407–3415. doi: 10.1093/hmg/ddw183
McCormack, A., Edmondson-Jones, M., Somerset, S., and Hall, D. (2016). A systematic review of the reporting of tinnitus prevalence and severity. Hear. Res. 337, 70–79. doi: 10.1016/j.heares.2016.05.009
Muller, K., Edvall, N. K., Idrizbegovic, E., Huhn, R., Cima, R., Persson, V., et al. (2016). Validation of online versions of tinnitus questionnaires translated into Swedish. Front. Aging Neurosci. 8:272. doi: 10.3389/fnagi.2016.00272
Pawelczyk, M., Rajkowska, E., Kotylo, P., Dudarewicz, A., Van Camp, G., and Sliwinska-Kowalska, M. (2012). Analysis of inner ear potassium recycling genes as potential factors associated with tinnitus. Int. J. Occup. Med. Environ. Health 25, 356–364. doi: 10.2478/S13382-012-0061-3
Requena, T., Cabrera, S., Martin-Sierra, C., Price, S. D., Lysakowski, A., and Lopez-Escamez, J. A. (2015). Identification of two novel mutations in FAM136A and DTNA genes in autosomal-dominant familial Meniere’s disease. Hum. Mol. Genet. 24, 1119–1126. doi: 10.1093/hmg/ddu524
Sand, P. G., Langguth, B., Itzhacki, J., Bauer, A., Geis, S., Cardenas-Conejo, Z. E., et al. (2012a). Resequencing of the auxiliary GABA(B) receptor subunit gene KCTD12 in chronic tinnitus. Front. Syst. Neurosci. 6:41. doi: 10.3389/fnsys.2012.00041
Sand, P. G., Langguth, B., and Kleinjung, T. (2011). Deep resequencing of the voltage-gated potassium channel subunit KCNE3 gene in chronic tinnitus. Behav. Brain Funct. 7:39. doi: 10.1186/1744-9081-7-39
Schlee, W., Hall, D., Edvall, N. K., Langguth, B., Canlon, B., and Cederroth, C. R. (2017). Visualization of global disease burden for the optimization of patient management and treatment. Front. Med. 4:86. doi: 10.3389/fmed.2017.00086
Keywords: tinnitus, genetics, heritability, subtype, neuropsychiatry, GWAS (genome-wide association study), whole exome sequencing
Citation: Cederroth CR, Kähler AK, Sullivan PF and Lopez-Escamez JA (2017) Genetics of Tinnitus: Time to Biobank Phantom Sounds. Front. Genet. 8:110. doi: 10.3389/fgene.2017.00110
Received: 10 July 2017; Accepted: 09 August 2017;
Published: 04 September 2017.
Edited by:M. Geoffrey Hayes, Northwestern University, United States
Reviewed by:Srikantan S. Nagarajan, University of California, San Francisco, United States
Fernando Cendes, Universidade Estadual de Campinas, Brazil
Copyright © 2017 Cederroth, Kähler, Sullivan and Lopez-Escamez. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.